Megan Seibel

Megan Seibel is an Associate Scientist at Celcuity since March 2023, previously serving as a Senior Research Associate at Vyant Bio from May 2022 to February 2023, where work focused on optimizing human induced pluripotent stem cell culture conditions and developing organoid models for Rett Syndrome drug screening. Prior experience includes an Advanced Research Associate position at Bio-Techne, where an innovative high throughput transient transfection model system for SARS-CoV2 spike protein variants was established, and a Researcher role at the Masonic Cancer Center, University of Minnesota-Twin Cities, investigating progesterone receptor isoforms in ovarian carcinoma. Earlier, as a Junior Scientist, Megan contributed to research on progesterone receptor signaling in hereditary BRCA1/2 ovarian cancer, and as an Undergraduate Research Assistant at the University of Wisconsin-Madison, participated in behavioral neuroendocrinology studies. Megan earned a Bachelor of Science in Biochemistry from the University of Wisconsin-Madison in 2015.